HRX215

· HepaRegeniX GmbH

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HRX215, covering 2026-04-20 to 2026-04-20. Get the full timeline:

Most recent: Clinical Trial Update: Safety of HRX215 in Patients After Minor and Major Liver Resection [Phase 1, Phase 2]